| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0008 |